{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1+-+Experimental+Trial&page=2", "query": { "intervention": "Part 1 - Experimental Trial", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1+-+Experimental+Trial&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T00:21:57.853Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04399889", "title": "hCT-MSCs for COVID19 ARDS", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "COVID", "Corona Virus Infection", "COVID19" ], "interventions": [ { "name": "Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Joanne Kurtzberg, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2020-06-18", "completion_date": "2022-02-16", "has_results": true, "last_update_posted_date": "2022-12-20", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 5, "location_summary": "Boca Raton, Florida • Miami, Florida • Valhalla, New York + 1 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Valhalla", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04399889" }, { "nct_id": "NCT05348395", "title": "Monocyte Priming When Consuming a Western Diet", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Diseases" ], "interventions": [ { "name": "Experimental diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "20 Years to 45 Years" }, "enrollment_count": 8, "start_date": "2023-01-06", "completion_date": "2024-10-11", "has_results": true, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05348395" }, { "nct_id": "NCT00624650", "title": "Hemodynamics and Extravascular Lung Water in Acute Lung Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lung Injury" ], "interventions": [ { "name": "Diuresis (furosemide) part I", "type": "DRUG" }, { "name": "Fluid Bolus (crystalloid or albumin)", "type": "OTHER" }, { "name": "Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine)", "type": "DRUG" }, { "name": "Dobutamine", "type": "DRUG" }, { "name": "Concentrate all drips and nutrition", "type": "OTHER" }, { "name": "Diuresis (furosemide) part II", "type": "DRUG" }, { "name": "Dialysis", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2008-02", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 3, "location_summary": "Clackamas, Oregon • Portland, Oregon", "locations": [ { "city": "Clackamas", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624650" }, { "nct_id": "NCT04460703", "title": "COVID-19 Vaccine Messaging, Part 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vaccination", "COVID-19" ], "interventions": [ { "name": "Control message", "type": "OTHER" }, { "name": "Baseline message", "type": "OTHER" }, { "name": "Personal freedom message", "type": "OTHER" }, { "name": "Economic freedom message", "type": "OTHER" }, { "name": "Self-interest message", "type": "OTHER" }, { "name": "Community interest message", "type": "OTHER" }, { "name": "Economic benefit message", "type": "OTHER" }, { "name": "Guilt message", "type": "OTHER" }, { "name": "Embarrassment message", "type": "OTHER" }, { "name": "Anger message", "type": "OTHER" }, { "name": "Trust in science message", "type": "OTHER" }, { "name": "Not bravery message", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4000, "start_date": "2020-07-03", "completion_date": "2020-07-08", "has_results": false, "last_update_posted_date": "2022-05-05", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04460703" }, { "nct_id": "NCT04729907", "title": "A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Muscular Atrophy, Spinal" ], "interventions": [ { "name": "Nusinersen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 115, "start_date": "2021-04-19", "completion_date": "2026-07-30", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 7, "location_summary": "Sacramento, California • Aurora, Colorado • Chicago, Illinois + 4 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04729907" }, { "nct_id": "NCT01618357", "title": "Pre-Operative Radiation and Veliparib for Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Radiation", "type": "RADIATION" }, { "name": "Lumpectomy/Mastectomy", "type": "PROCEDURE" }, { "name": "Veliparib", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "DRUG" ], "sponsor": "Richard Zellars", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 19, "start_date": "2013-07-22", "completion_date": "2023-10-17", "has_results": false, "last_update_posted_date": "2024-05-22", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 6, "location_summary": "Avon, Indiana • Carmel, Indiana • Indianapolis, Indiana", "locations": [ { "city": "Avon", "state": "Indiana" }, { "city": "Carmel", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01618357" }, { "nct_id": "NCT05508009", "title": "Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "SIOD", "Cystinosis", "FSGS", "SLE Nephritis", "CKD Stage 4" ], "interventions": [ { "name": "Cyclophosphamide 1200 mg/Kg", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide 100 mg/Kg", "type": "DRUG" }, { "name": "Total Body Irradiation", "type": "RADIATION" }, { "name": "ATG", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System", "type": "DEVICE" }, { "name": "Kidney Transplant", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "DEVICE", "PROCEDURE" ], "sponsor": "Alice Bertaina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 12, "start_date": "2023-01-10", "completion_date": "2034-10", "has_results": false, "last_update_posted_date": "2023-07-17", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05508009" }, { "nct_id": "NCT04933799", "title": "IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COVID-19 Pneumonia" ], "interventions": [ { "name": "PF-06650833", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Giovanni Franchin, M.D, Ph.D", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2021-01-06", "completion_date": "2022-05-06", "has_results": false, "last_update_posted_date": "2021-06-22", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04933799" }, { "nct_id": "NCT05432583", "title": "A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Genital Herpes Simplex Type 2" ], "interventions": [ { "name": "BNT163", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 318, "start_date": "2022-12-08", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 6, "location_summary": "Tempe, Arizona • Chicago, Illinois • Raleigh, North Carolina + 3 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Wilmington", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05432583" }, { "nct_id": "NCT02432456", "title": "Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Wounds and Injuries", "Rib Fractures" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Intercostal Nerve Block", "type": "PROCEDURE" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Pantoprazole", "type": "DRUG" }, { "name": "Methocarbamol", "type": "DRUG" }, { "name": "Opioid", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Medical College of Wisconsin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 153, "start_date": "2015-09", "completion_date": "2018-08", "has_results": true, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-09-24T00:21:57.853Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02432456" } ] }